These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
73 related articles for article (PubMed ID: 9554872)
1. Effect of steroids on DNA synthesis in an in vitro replication system: initial quantitative structure-activity relationship studies and construction of a non-estrogen receptor pharmacophore. Azzaoui K; Diaz-Perez MJ; Zannis-Hadjoupoulos M; Price GB; Wainer IW J Med Chem; 1998 Apr; 41(9):1392-8. PubMed ID: 9554872 [TBL] [Abstract][Full Text] [Related]
2. Improving the quality of 3D-QSAR by using flexible-ligand receptor models. Pei J; Chen H; Liu Z; Han X; Wang Q; Shen B; Zhou J; Lai L J Chem Inf Model; 2005; 45(6):1920-33. PubMed ID: 16309299 [TBL] [Abstract][Full Text] [Related]
3. Hologram quantitative structure-activity relationships for a series of farnesoid X receptor activators. Honorio KM; Garratt RC; Andricopulo AD Bioorg Med Chem Lett; 2005 Jun; 15(12):3119-25. PubMed ID: 15893927 [TBL] [Abstract][Full Text] [Related]
5. CAUTION: popular "benchmark" data sets do not distinguish the merits of 3D QSAR methods. Manchester J; Czermiński R J Chem Inf Model; 2009 Jun; 49(6):1449-54. PubMed ID: 19438212 [TBL] [Abstract][Full Text] [Related]
6. Pharmacophoric search and 3D-QSAR comparative molecular field analysis studies on agonists of melatonin sheep receptors. Marot C; Chavatte P; Morin-Allory L; Viaud MC; Guillaumet G; Renard P; Lesieur D; Michel A J Med Chem; 1998 Nov; 41(23):4453-65. PubMed ID: 9804685 [TBL] [Abstract][Full Text] [Related]
7. High-throughput screening of ecdysone agonists using a reporter gene assay followed by 3-D QSAR analysis of the molting hormonal activity. Wheelock CE; Nakagawa Y; Harada T; Oikawa N; Akamatsu M; Smagghe G; Stefanou D; Iatrou K; Swevers L Bioorg Med Chem; 2006 Feb; 14(4):1143-59. PubMed ID: 16249087 [TBL] [Abstract][Full Text] [Related]
8. Resurrecting the ancestral steroid receptor: ancient origin of estrogen signaling. Thornton JW; Need E; Crews D Science; 2003 Sep; 301(5640):1714-7. PubMed ID: 14500980 [TBL] [Abstract][Full Text] [Related]
9. Development of a chirality-sensitive flexibility descriptor for 3+3D-QSAR. Dervarics M; Otvös F; Martinek TA J Chem Inf Model; 2006; 46(3):1431-8. PubMed ID: 16711763 [TBL] [Abstract][Full Text] [Related]
10. Synthesis of ponasterone A derivatives with various steroid skeleton moieties and evaluation of their binding to the ecdysone receptor of Kc cells. Arai H; Watanabe B; Nakagawa Y; Miyagawa H Steroids; 2008 Dec; 73(14):1452-64. PubMed ID: 18804484 [TBL] [Abstract][Full Text] [Related]
11. CoMFA-based prediction of agonist affinities at recombinant D1 vs D2 dopamine receptors. Wilcox RE; Tseng T; Brusniak MY; Ginsburg B; Pearlman RS; Teeter M; DuRand C; Starr S; Neve KA J Med Chem; 1998 Oct; 41(22):4385-99. PubMed ID: 9784114 [TBL] [Abstract][Full Text] [Related]
12. Fast three dimensional pharmacophore virtual screening of new potent non-steroid aromatase inhibitors. Neves MA; Dinis TC; Colombo G; Sá e Melo ML J Med Chem; 2009 Jan; 52(1):143-50. PubMed ID: 19072235 [TBL] [Abstract][Full Text] [Related]
13. A three-dimensional model of the delta-opioid pharmacophore: comparative molecular modeling of peptide and nonpeptide ligands. Shenderovich MD; Liao S; Qian X; Hruby VJ Biopolymers; 2000 Jun; 53(7):565-80. PubMed ID: 10766952 [TBL] [Abstract][Full Text] [Related]
14. Neurosteroid analogues. 14. Alternative ring system scaffolds: GABA modulatory and anesthetic actions of cyclopenta[b]phenanthrenes and cyclopenta[b]anthracenes. Scaglione JB; Jastrzebska I; Krishnan K; Li P; Akk G; Manion BD; Benz A; Taylor A; Rath NP; Evers AS; Zorumski CF; Mennerick S; Covey DF J Med Chem; 2008 Mar; 51(5):1309-18. PubMed ID: 18275132 [TBL] [Abstract][Full Text] [Related]
15. Structure-based approach to pharmacophore identification, in silico screening, and three-dimensional quantitative structure-activity relationship studies for inhibitors of Trypanosoma cruzi dihydrofolate reductase function. Schormann N; Senkovich O; Walker K; Wright DL; Anderson AC; Rosowsky A; Ananthan S; Shinkre B; Velu S; Chattopadhyay D Proteins; 2008 Dec; 73(4):889-901. PubMed ID: 18536013 [TBL] [Abstract][Full Text] [Related]
16. Three-dimensional models of histamine H3 receptor antagonist complexes and their pharmacophore. Axe FU; Bembenek SD; Szalma S J Mol Graph Model; 2006 May; 24(6):456-64. PubMed ID: 16386444 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of hydrogen bonds of ecdysteroids in the ligand-receptor interactions using a protein modeling system. Harada T; Nakagawa Y; Akamatsu M; Miyagawa H Bioorg Med Chem; 2009 Aug; 17(16):5868-73. PubMed ID: 19631551 [TBL] [Abstract][Full Text] [Related]
18. Structure-activity relationships and effects on neuroactive steroid synthesis in a series of 2-phenylimidazo[1,2-a]pyridineacetamide peripheral benzodiazepine receptors ligands. Trapani G; Laquintana V; Denora N; Trapani A; Lopedota A; Latrofa A; Franco M; Serra M; Pisu MG; Floris I; Sanna E; Biggio G; Liso G J Med Chem; 2005 Jan; 48(1):292-305. PubMed ID: 15634024 [TBL] [Abstract][Full Text] [Related]
19. Mixed-model QSAR at the human mineralocorticoid receptor: predicting binding mode and affinity of anabolic steroids. Peristera O; Spreafico M; Smiesko M; Ernst B; Vedani A Toxicol Lett; 2009 Sep; 189(3):219-24. PubMed ID: 19523507 [TBL] [Abstract][Full Text] [Related]
20. Probing the pharmacophore for allosteric ligands of muscarinic M2 receptors: SAR and QSAR studies in a series of bisquaternary salts of caracurine V and related ring systems. Zlotos DP; Buller S; Stiefl N; Baumann K; Mohr K J Med Chem; 2004 Jul; 47(14):3561-71. PubMed ID: 15214783 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]